Last reviewed · How we verify

NCT02324062: HCP

Cancer Genetics Hereditary Cancer Panel Testing

Completed Last updated 18 February 2026
What this trial tests

trial testing Questionnaires in Hereditary Breast and Ovarian Cancer in 1,511 participants. Completed in 31 August 2020.

Timeline
12 June 2014
Primary endpoint
31 August 2020
31 August 2020

Quick facts

Lead sponsorUniversity of Southern California
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,511
Start date12 June 2014
Primary completion31 August 2020
Estimated completion31 August 2020
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Southern California

Who can join

Eligibility, any sex, with Hereditary Breast and Ovarian Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is about understanding the use of a genetic test (Myriad Genetics myRisk panel) that analyzes 25 genes related to different hereditary cancer conditions. The investigators hope to learn more about how this type of genetic test is used clinically. The investigators also hope to understand more about the experience of individuals and families who undergoing this test of genetic testing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Questionnaires

Trials testing the same drug.

Other recruiting trials for Hereditary Breast and Ovarian Cancer

Currently open trials in the same condition.

Other University of Southern California trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02324062.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing